{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:43:33Z","timestamp":1790981013118,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Gout, the most common type of inflammatory arthritis in the world, is characterized by painful episodes of arthritis linked by asymptomatic intercritical periods of hyperuricemia. Once characterized as a disease of wealthy white men, contemporary evidence demonstrates gout disproportionately afflicts racial\/ethnic minorities, Indigenous populations and other underrepresented groups leading to significant health disparities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Herein, we review the current literature reporting a higher incidence and prevalence of gout in racial\/ethnic minorities and Indigenous populations, in addition to a growing gout burden reported in females. We also examine how these population are more likely to receive suboptimal treatment for flares and chronic phases of gout. Additionally, we examine biologic and social health determinants that may be contributing to these findings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Racial\/ethnic minorities, Indigenous populations, and females have experienced a disproportionate rise in the prevalence and incidence of gout in recent years, are more likely to seek acute medical care and are less likely to receive optimal long-term care for gout with urate lowering therapy. Mechanisms underpinning these findings appear to be multifactorial and include differences in social determinants of care and in some cases may be due to population differences in select biologic factors such as differences in age, sex, genetics.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000996","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T12:00:09Z","timestamp":1703246409000},"page":"120-125","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Health disparities in gout"],"prefix":"10.1097","volume":"36","author":[{"given":"Lindsay N.","family":"Helget","sequence":"first","affiliation":[{"name":"Veterans Affairs Nebraska-Western Iowa Healthcare System"},{"name":"Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted R.","family":"Mikuls","sequence":"additional","affiliation":[{"name":"Veterans Affairs Nebraska-Western Iowa Healthcare System"},{"name":"Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,22]]},"reference":[{"key":"R1-20250526","first-page":"687","article-title":"Hippocrates and rheumatology","volume":"22","author":"Pasero","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/ard.29.5.461","article-title":"Clinical survey of 354 patients with gout","volume":"29","author":"Grahame","year":"1970","journal-title":"Ann Rheum Dis"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/art.40807","article-title":"Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey, 2007\u20132016","volume":"71","author":"Chen-Xu","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"e45943","DOI":"10.2196\/45943","article-title":"Global, regional, and national prevalence of gout from 1990 to 2019: age-period-cohort analysis with future burden prediction","volume":"9","author":"He","year":"2023","journal-title":"JMIR Public Health Surveill"},{"key":"R6-20250526","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007\u20132008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/acr.24339","article-title":"The incidence, prevalence, and burden of gout in the veterans health administration","volume":"73","author":"Helget","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/acr.21791","article-title":"Body mass index, obesity, and prevalent gout in the United States in 1988\u20131994 and 2007\u20132010","volume":"65","author":"Juraschek","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R10-20250526","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/acr.24881","article-title":"Cause-specific mortality in patients with gout in the United States Veteran's Health Administration: a matched cohort study","volume":"75","author":"Helget","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R11-20250526","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/rheumatology\/key096","article-title":"Comorbidity clusters in people with gout: an observational cohort study with linked medical record review","volume":"57","author":"Bevis","year":"2018","journal-title":"Rheumatology"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11926-017-0688-y","article-title":"Gout and metabolic syndrome: a tangled web","volume":"19","author":"Thottam","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"R13-20250526","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s10067-019-04868-9","article-title":"Recent updates on worldwide gout epidemiology","volume":"39","author":"Mattiuzzi","year":"2020","journal-title":"Clin Rheumatol"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/art.41404","article-title":"Prevalence, incidence, and years lived with disability due to gout and its attributable risk factors for 195 countries and territories 1990\u20132017: a systematic analysis of the global burden of disease study 2017","volume":"72","author":"Safiri","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3899\/jrheum.210394","article-title":"Modifiable factors and incident gout across ethnicity within a large multiethnic cohort of older adults","volume":"49","author":"Thompson","year":"2022","journal-title":"J Rheumatol"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"e2226804","DOI":"10.1001\/jamanetworkopen.2022.26804","article-title":"Racial and sex disparities in gout prevalence among US adults","volume":"5","author":"McCormick","year":"2022","journal-title":"JAMA Network Open"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"e239501","DOI":"10.1001\/jamanetworkopen.2023.9501","article-title":"Trends in prevalence of gout among US Asian adults, 2011\u20132018","volume":"6","author":"Yokose","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R18-20250526","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211028007","article-title":"Inequities in people with gout: a focus on Maori (Indigenous People) of Aotearoa New Zealand","volume":"13","author":"Te Karu","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/jpm11030231","article-title":"The epidemiology and genetics of hyperuricemia and gout across major racial groups: a literature review and population genetics secondary database analysis","volume":"11","author":"Butler","year":"2021","journal-title":"J Pers Med"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1093\/hmg\/ddq412","article-title":"A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Maori, case and control sample sets","volume":"19","author":"Phipps-Green","year":"2010","journal-title":"Hum Mol Genet"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/rheumatology\/keac590","article-title":"Nationwide racial\/ethnic disparities in US emergency department visits and hospitalizations for gout","volume":"62","author":"Yokose","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"R22-20250526","first-page":"8","article-title":"Gout in Aotearoa New Zealand: the equity crisis continues in plain sight","volume":"131","author":"Dalbeth","year":"2018","journal-title":"N Z Med J"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/acr.23928","article-title":"Prescription opioid use among acute gout patients discharged from the emergency department","volume":"72","author":"Dalal","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/acr.24180","article-title":"2020 American College of Rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R26-20250526","article-title":"Determinants of achieving serum urate goal with treat-to-target urate-lowering therapy in gout","author":"Helget","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1016\/j.numecd.2021.09.011","article-title":"Inequalities in enrollment of women and racial minorities in trials testing uric acid lowering drugs","volume":"31","author":"Fogacci","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R28-20250526","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","article-title":"Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial","volume":"392","author":"Doherty","year":"2018","journal-title":"Lancet"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s43441-020-00198-0","article-title":"Rebranding gout: could a name change for gout improve adherence to urate-lowering therapy?","volume":"55","author":"Coleshill","year":"2021","journal-title":"Ther Innov Regul Sci"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1071\/HC18082","article-title":"Facilitating equitable prevention and management of gout for Maori in Northland, New Zealand, through a collaborative primary care approach","volume":"11","author":"Lawrence","year":"2019","journal-title":"J Prim Healthc"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T21:16:07Z","timestamp":1748294167000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,22]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000996","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,22]]}}}